Annual EBITDA
$6.82B$707.00M+11.57%
Summary
- Current Value
- As of today, SYK annual EBITDA is $6.82B, up +11.57% on
- Historical Performance
- SYK annual EBITDA is up +44.08% over the past 3 years, up +81.28% over the past 5 years
- All-Time High Comparison
- SYK annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK annual EBITDA is +44.08% above its 3-year low of $4.73B reached on an earlier date
- Sector Comparison
- SYK annual EBITDA is higher than 98.05% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $6.82B | +11.6% | +44.1% | +81.3% | +201.6% | |
| Quarterly EBITDA | $1.85B | +10.3% | +47.3% | +63.2% | +213.9% | |
| TTM EBITDA | $7.67B | +13.2% | +49.1% | +65.5% | +234.6% | |
| Price | $313.08 | -14.0% | +8.6% | +18.7% | +554.8% | |
| PE Ratio | 33.35 | -30.3% | -22.0% | -37.1% | +119.7% | |
| Annual Revenue | $25.12B | +11.2% | +36.1% | +75.0% | +243.1% | |
| Annual EPS | $8.40 | +8.2% | +36.1% | +99.7% | +163.3% | |
| Annual EBIT | $5.63B | +11.1% | +50.6% | +90.7% | +204.0% | |
| Annual Net Income | $3.25B | +8.4% | +37.7% | +103.0% | +154.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.82B | at high | |
| 5Y | $6.82B | at high | |
| All | $6.82B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.73B | N/A | +44.1% |
| 5Y | $3.76B | N/A | +81.3% |
| All | $5.89M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of SYK?
- As of today, SYK annual EBITDA is $6.82B
- What is 1-year change in SYK annual EBITDA?
- SYK annual EBITDA is up +11.57% year-over-year
- What is 3-year change in SYK annual EBITDA?
- SYK annual EBITDA is up +44.08% over the past 3 years
- How far is SYK annual EBITDA from its all-time high?
- SYK annual EBITDA is currently at its all-time high
- How does SYK annual EBITDA rank versus sector peers?
- SYK annual EBITDA is higher than 98.05% of companies in Healthcare sector
- When is SYK next annual earnings release?
- The next annual earnings release for SYK is on
EBITDA Formula
Quarterly EBITDA
$1.85B$264.00M-12.51%
Summary
- Current Value
- As of today, SYK quarterly EBITDA is $1.85B, down -12.51% on
- Historical Performance
- SYK quarterly EBITDA is up +10.34% year-over-year, up +47.33% over the past 3 years
- All-Time High Comparison
- SYK quarterly EBITDA is currently -19.91% below its historical high of $2.31B set on
- 3-Year Low Comparison
- SYK quarterly EBITDA is +47.33% above its 3-year low of $1.25B reached on an earlier date
- Sector Comparison
- SYK quarterly EBITDA is higher than 97.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.85B | -12.5% | +10.3% | +47.3% | +63.2% | |
| Annual EBITDA | $6.82B | – | +11.6% | +44.1% | +81.3% | |
| TTM EBITDA | $7.67B | +2.3% | +13.2% | +49.1% | +65.5% | |
| Price | $313.08 | -7.9% | -14.0% | +8.6% | +18.7% | |
| PE Ratio | 33.35 | -5.3% | -30.3% | -22.0% | -37.1% | |
| Quarterly Revenue | $6.52B | -1.1% | +7.6% | +32.8% | +56.7% | |
| Quarterly EPS | $1.96 | -40.8% | -11.9% | +8.6% | +71.0% | |
| Quarterly EBIT | $1.55B | -14.5% | +13.7% | +56.5% | +73.1% | |
| Quarterly Net Income | $753.00M | -41.0% | -12.3% | +8.8% | +71.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.31B | -19.9% | |
| 3Y | $2.31B | -19.9% | |
| 5Y | $2.31B | -19.9% | |
| All | $2.31B | -19.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.40B | +31.5% | |
| 3Y | $1.25B | N/A | +47.3% |
| 5Y | $1.03B | +79.9% | |
| All | -$104.50M | +1866.5% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of SYK?
- As of today, SYK quarterly EBITDA is $1.85B
- What is SYK quarterly EBITDA most recent change?
- SYK quarterly EBITDA was down -12.51% on September 30, 2026
- What is 1-year change in SYK quarterly EBITDA?
- SYK quarterly EBITDA is up +10.34% year-over-year
- How far is SYK quarterly EBITDA from its all-time high?
- SYK quarterly EBITDA is currently -19.91% below its historical high of $2.31B set on December 31, 2025
- How does SYK quarterly EBITDA rank versus sector peers?
- SYK quarterly EBITDA is higher than 97.59% of companies in Healthcare sector
- When is SYK next earnings release?
- The next earnings release for SYK is on
EBITDA Formula
TTM EBITDA
$7.67B$173.00M+2.31%
Summary
- Current Value
- As of today, SYK TTM EBITDA is $7.67B, up +2.31% on
- Historical Performance
- SYK TTM EBITDA is up +13.20% year-over-year, up +49.15% over the past 3 years
- All-Time High Comparison
- SYK TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK TTM EBITDA is +49.15% above its 3-year low of $5.14B reached on an earlier date
- Sector Comparison
- SYK TTM EBITDA is higher than 97.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $7.67B | +2.3% | +13.2% | +49.1% | +65.5% | |
| Annual EBITDA | $6.82B | – | +11.6% | +44.1% | +81.3% | |
| Quarterly EBITDA | $1.85B | -12.5% | +10.3% | +47.3% | +63.2% | |
| Price | $313.08 | -7.9% | -14.0% | +8.6% | +18.7% | |
| PE Ratio | 33.35 | -5.3% | -30.3% | -22.0% | -37.1% | |
| TTM Revenue | $26.30B | +1.8% | +7.9% | +32.3% | +57.8% | |
| TTM EPS | $9.39 | -2.7% | +23.3% | +39.2% | +88.7% | |
| TTM EBIT | $6.46B | +3.0% | +14.7% | +57.2% | +76.6% | |
| TTM Net Income | $3.62B | -2.8% | +23.1% | +40.1% | +90.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.67B | at high | |
| 3Y | $7.67B | at high | |
| 5Y | $7.67B | at high | |
| All | $7.67B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.77B | N/A | +13.2% |
| 3Y | $5.14B | N/A | +49.1% |
| 5Y | $4.61B | +66.2% | |
| All | -$32.20M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of SYK?
- As of today, SYK TTM EBITDA is $7.67B
- What is SYK TTM EBITDA most recent change?
- SYK TTM EBITDA was up +2.31% on September 30, 2026
- What is 1-year change in SYK TTM EBITDA?
- SYK TTM EBITDA is up +13.20% year-over-year
- How far is SYK TTM EBITDA from its all-time high?
- SYK TTM EBITDA is currently at its all-time high
- How does SYK TTM EBITDA rank versus sector peers?
- SYK TTM EBITDA is higher than 97.69% of companies in Healthcare sector
- When is SYK next earnings release?
- The next earnings release for SYK is on
EBITDA Formula
Data Sources & References
- SYK Official Website www.stryker.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/310764/000031076426000006/0000310764-26-000006-index.htm
- SYK Profile on Yahoo Finance finance.yahoo.com/quote/SYK
- SYK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syk
